Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma
Name:
s00330-024-11168-7.pdf
Size:
2.603Mb
Format:
PDF
Description:
Found with Open Access Button
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK. Department of Radiology, The Christie Hospital, Manchester, UK.Issue Date
2024
Metadata
Show full item recordAbstract
PURPOSE: To assess the effect of different intensity standardisation techniques (ISTs) and ComBat batch sizes on radiomics survival model performance and stability in a heterogenous, multi-centre cohort of patients with glioblastoma (GBM). METHODS: Multi-centre pre-operative MRI acquired between 2014 and 2020 in patients with IDH-wildtype unifocal WHO grade 4 GBM were retrospectively evaluated. WhiteStripe (WS), Nyul histogram matching (HM), and Z-score (ZS) ISTs were applied before radiomic feature (RF) extraction. RFs were realigned using ComBat and minimum batch size (MBS) of 5, 10, or 15 patients. Cox proportional hazards models for overall survival (OS) prediction were produced using five different selection strategies and the impact of IST and MBS was evaluated using bootstrapping. Calibration, discrimination, relative explained variation, and model fit were assessed. Instability was evaluated using 95% confidence intervals (95% CIs), feature selection frequency and calibration curves across the bootstrap resamples. RESULTS: One hundred ninety-five patients were included. Median OS = 13 (95% CI: 12-14) months. Twelve to fourteen unique MRI protocols were used per MRI sequence. HM and WS produced the highest relative increase in model discrimination, explained variation and model fit but IST choice did not greatly impact on stability, nor calibration. Larger ComBat batches improved discrimination, model fit, and explained variation but higher MBS (reduced sample size) reduced stability (across all performance metrics) and reduced calibration accuracy. CONCLUSION: Heterogenous, real-world GBM data poses a challenge to the reproducibility of radiomics. ComBat generally improved model performance as MBS increased but reduced stability and calibration. HM and WS tended to improve model performance. KEY POINTS: Question ComBat harmonisation of RFs and intensity standardisation of MRI have not been thoroughly evaluated in multicentre, heterogeneous GBM data. Findings The addition of ComBat and ISTs can improve discrimination, relative model fit, and explained variance but degrades the calibration and stability of survival models. Clinical relevance Radiomics risk prediction models in real-world, multicentre contexts could be improved by ComBat and ISTs, however, this degrades calibration and prediction stability and this must be thoroughly investigated before patients can be accurately separated into different risk groups.Citation
Fatania K, Frood R, Mistry H, Short SC, O'Connor J, Scarsbrook AF, et al. Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma. European radiology. 2024 Nov 28. PubMed PMID: 39607450. Epub 2024/11/28. eng.Journal
European RadiologyDOI
10.1007/s00330-024-11168-7PubMed ID
39607450Additional Links
https://dx.doi.org/10.1007/s00330-024-11168-7Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1007/s00330-024-11168-7
Scopus Count
Collections
Related articles
- Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
- Authors: Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH
- Issue date: 2024 Dec 1
- Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
- Authors: Huang CC, Peng KP, Hsieh HC, Groot OQ, Yen HK, Tsai CC, Karhade AV, Lin YP, Kao YT, Yang JJ, Dai SH, Huang CC, Chen CW, Yen MH, Xiao FR, Lin WH, Verlaan JJ, Schwab JH, Hsu FM, Wong T, Yang RS, Yang SH, Hu MH
- Issue date: 2024 Jan 1
- Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.
- Authors: Reeve K, On BI, Havla J, Burns J, Gosteli-Peter MA, Alabsawi A, Alayash Z, Götschi A, Seibold H, Mansmann U, Held U
- Issue date: 2023 Sep 8
- Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
- Authors: Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF
- Issue date: 2022 Oct
- Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
- Authors: Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ
- Issue date: 2023 May 11